Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene

Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene

US Patent 12448613 · Granted Oct 21, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Rationally-designed single-chain meganucleases with non-palindromic recognition 2025
Methods for producing a complex transgenic trait locus2025
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Polynucleotides encoding engineered meganucleases having specificity for recogni2024
Polynucleotides encoding engineered meganucleases having specificity for recogni2023
Engineered meganucleases specific for recognition sequences in the PCSK9 gene2023
Methods for producing a complex transgenic trait locus2022
Co-stimulatory domains for use in genetically-modified cells2022
Engineered nucleases useful for treatment of hemophilia A2022
Engineered nucleases useful for treatment of hemophilia A2022
Engineered meganucleases specific for recognition sequences in the Hepatitis B v2022
Nucleic acids encoding engineered meganucleases with recognition sequences found2022